Jessica Flechtner - Dec 31, 2021 Form 5 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
Chief Scientific Officer
Signature
/s/ Diantha Duvall, Attorney-in-Fact for Jessica Flechtner
Stock symbol
GNCA
Transactions as of
Dec 31, 2021
Transactions value $
-$4,594
Form type
5
Date filed
3/16/2022, 05:32 PM
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale -$3.16K -1.17K -1.67% $2.71 68.6K Apr 2, 2021 Direct F1
transaction GNCA Common Stock Sale -$1.43K -643 -0.94% $2.23 67.9K Jun 1, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.